Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinoma

被引:5
|
作者
Nan, Yuemin [1 ]
Zhao, Suxian [1 ]
Zhang, Xiaoxiao [1 ]
Xiao, Zhifeng [2 ]
Guo, Ruihan [3 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Hebei Prov Key Lab Liver Fibrosis Chron Liver Dis, Shijiazhuang, Peoples R China
[2] Behrend Coll, Sch Engn, Penn State Erie, Erie, PA USA
[3] Shanghai Ashermed Healthcare Co Ltd, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
hepatocellular carcinoma; blood biomarkers; machine learning; hepatitis B; cirrhosis; risk model; immunotherapy;
D O I
10.3389/fimmu.2022.1031400
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B Virus (HBV) infection may lead to various liver diseases such as cirrhosis, end-stage liver complications, and Hepatocellular carcinoma (HCC). Patients with existing cirrhosis or severe fibrosis have an increased chance of developing HCC. Consequently, lifetime observation is currently advised. This study gathered real-world electronic health record (EHR) data from the China Registry of Hepatitis B (CR-HepB) database. A collection of 396 patients with HBV infection at different stages were obtained, including 1) patients with a sustained virological response (SVR), 2) patients with HBV chronic infection and without further development, 3) patients with cirrhosis, and 4) patients with HCC. Each patient has been monitored periodically, yielding multiple visit records, each is described using forty blood biomarkers. These records can be utilized to train predictive models. Specifically, we develop three machine learning (ML)-based models for three learning tasks, including 1) an SVR risk model for HBV patients via a survival analysis model, 2) a risk model to encode the progression from HBV, cirrhosis and HCC using dimension reduction and clustering techniques, and 3) a classifier to detect HCC using the visit records with high accuracy (over 95%). Our study shows the potential of offering a comprehensive understanding of HBV progression via predictive analysis and identifies the most indicative blood biomarkers, which may serve as biomarkers that can be used for immunotherapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data
    Hu, Yingying
    Chen, Ruijia
    Ye, Zhenjie
    Wei, Fuqun
    Lin, Kecan
    Liu, Jingfeng
    Zeng, Yongyi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12) : 1507 - 1517
  • [22] Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery
    Johnston, Stephen S.
    Morton, John M.
    Kalsekar, Iftekhar
    Ammann, Eric M.
    Hsiao, Chia-Wen
    Reps, Jenna
    VALUE IN HEALTH, 2019, 22 (05) : 580 - 586
  • [23] Machine Learning-Based Identification of Risk Factors of Keratoconus Progression Using Raw Corneal Tomography Data
    Cohen-Tayar, Yamit
    Cohen, Hadar
    Key, Dor
    Tiosano, Alon
    Rozanes, Eliane
    Livny, Eitan
    Bahar, Irit
    Nahum, Yoav
    CORNEA, 2025, 44 (05) : 605 - 612
  • [24] Increased risk of hepatocellular carcinoma in patients with traumatic liver injury Real-world data from a nationwide population-based study
    Chen, Yen-Ju
    Shen, Chih-Jung
    Yu, Shao-Hua
    Lin, Cheng-Li
    Shih, Hong-Mo
    MEDICINE, 2022, 101 (06)
  • [25] Novel Machine Learning Identifies 5 Asthma Phenotypes Using Cluster Analysis of Real-World Data
    Wu, Chao-Ping
    Sleiman, Joelle
    Fakhry, Battoul
    Chedraoui, Celine
    Attaway, Amy
    Bhattacharyya, Anirban
    Bleecker, Eugene R.
    Erdemir, Ahmet
    Hu, Bo
    Kethireddy, Shravan
    Meyers, Deborah A.
    Rashidi, Hooman H.
    Zein, Joe G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08) : 2084 - 2091.e4
  • [26] Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine Learning
    Johansson, Fredrik D.
    Collins, Jamie E.
    Yau, Vincent
    Guan, Hongshu
    Kim, Seoyoung C.
    Losina, Elena
    Sontag, David
    Stratton, Jacklyn
    Trinh, Huong
    Greenberg, Jeffrey
    Solomon, Daniel H.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (09) : 1364 - 1370
  • [27] Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study
    Hu, Zili
    Hu, Zhiwen
    Zhan, Weixiang
    Wu, Weijie
    Zhou, Zhongguo
    Chen, Minshan
    Fu, Yizhen
    Zhang, Yaojun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127
  • [28] Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
    Su, Na
    Tang, Rui
    Zhang, Yice
    Ni, Jiaqi
    Huang, Yimei
    Liu, Chunqi
    Xiao, Yuzhou
    Zhu, Baoting
    Zhao, Yinglan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] An Interpretable Machine Learning-Based Hurdle Model for Zero-Inflated Road Crash Frequency Data Analysis: Real-World Assessment and Validation
    Khedher, Moataz Bellah Ben
    Yun, Dukgeun
    APPLIED SCIENCES-BASEL, 2024, 14 (23):
  • [30] Predicting quetiapine dose in patients with depression using machine learning techniques based on real-world evidence
    Yupei Hao
    Jinyuan Zhang
    Jing Yu
    Ze Yu
    Lin Yang
    Xin Hao
    Fei Gao
    Chunhua Zhou
    Annals of General Psychiatry, 23